BioLargo Inc
OTC:BLGO
BioLargo Inc
OTC:BLGO
Price:
0.1698
USD
-0.12%
Market Closed
Market Cap:
$53.3m
Balance Sheet
Balance Sheet Decomposition
BioLargo Inc
BioLargo Inc
Balance Sheet Decomposition is not available for
BioLargo Inc
BioLargo Inc
Balance Sheet
BioLargo Inc
BioLargo Inc
Currency: USD
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
4
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
4
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
2
|
2
|
3
|
6
|
7
|
|
| PP&E Net |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
2
|
3
|
|
| PP&E Gross |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
4
|
0
|
0
|
0
|
0
|
11
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Assets |
5
N/A
|
4
-5%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-11%
|
11
+4 484%
|
10
-13%
|
0
-98%
|
0
+156%
|
0
-46%
|
0
+8%
|
0
-37%
|
0
+53%
|
2
+635%
|
2
+10%
|
2
-29%
|
3
+113%
|
4
+13%
|
5
+36%
|
3
-39%
|
5
+61%
|
8
+69%
|
11
+28%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
1
|
2
|
2
|
2
|
2
|
1
|
0
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
3
|
2
|
3
|
4
|
5
|
5
|
2
|
2
|
3
|
2
|
1
|
1
|
1
|
1
|
0
|
1
|
4
|
2
|
4
|
4
|
1
|
2
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
4
|
4
|
3
|
3
|
3
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
|
| Total Liabilities |
3
N/A
|
2
-29%
|
3
+22%
|
4
+27%
|
5
+37%
|
6
+10%
|
2
-57%
|
3
+10%
|
4
+52%
|
3
-25%
|
2
-42%
|
1
-68%
|
1
+7%
|
1
+18%
|
2
+120%
|
3
+121%
|
6
+63%
|
5
-16%
|
6
+23%
|
1
-81%
|
2
N/A
|
0
+99%
|
1
N/A
|
2
+22%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
18
|
26
|
27
|
28
|
30
|
35
|
42
|
58
|
64
|
67
|
73
|
75
|
79
|
84
|
92
|
101
|
112
|
123
|
132
|
139
|
144
|
147
|
150
|
|
| Additional Paid In Capital |
15
|
20
|
23
|
23
|
23
|
24
|
44
|
49
|
54
|
61
|
66
|
72
|
75
|
79
|
84
|
91
|
97
|
110
|
121
|
136
|
144
|
148
|
154
|
158
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
+64%
|
3
N/A
|
4
-27%
|
5
-29%
|
5
-11%
|
9
N/A
|
7
-19%
|
4
N/A
|
3
+33%
|
2
+41%
|
0
+81%
|
0
-48%
|
0
-5%
|
0
N/A
|
1
N/A
|
4
-208%
|
2
+63%
|
2
-43%
|
4
N/A
|
5
+20%
|
5
+5%
|
7
+40%
|
9
+29%
|
|
| Total Liabilities & Equity |
5
N/A
|
4
-5%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-11%
|
11
+4 484%
|
10
-13%
|
0
-98%
|
0
+156%
|
0
-46%
|
0
+8%
|
0
-37%
|
0
+53%
|
2
+635%
|
2
+10%
|
2
-29%
|
3
+113%
|
4
+13%
|
5
+36%
|
3
-39%
|
5
+61%
|
8
+69%
|
11
+28%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
1
|
1
|
2
|
3
|
3
|
40
|
42
|
43
|
52
|
59
|
71
|
75
|
83
|
86
|
93
|
104
|
141
|
141
|
166
|
256
|
278
|
293
|
301
|
|
| Preferred Shares Outstanding |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
